General Information of the Compound
Compound ID
CP0071075
Compound Name
4-fluoro-N-(4-(6-(isopropylamino)pyrimidin-4-yl)thiazol-2-yl)-N-methylbenzamide
    Show/Hide
Synonyms
Anti-alpha-5/beta-1 integrin Ab Fragment, PDL
Anti-alpha-5/beta-1 integrin Fab, PDL
Anti-alpha-5/beta-1 integrin Fab, Protein Design Labs
Eos-200-F
F-200
    Show/Hide
Structure
Formula
C18H18FN5OS
Molecular Weight
371.441
Canonical SMILES
CC(C)Nc1cc(ncn1)-c1csc(n1)N(C)C(=O)c1ccc(F)cc1
    Show/Hide
InChI
InChI=1S/C18H18FN5OS/c1-11(2)22-16-8-14(20-10-21-16)15-9-26-18(23-15)24(3)17(25)12-4-6-13(19)7-5-12/h4-11H,1-3H3,(H,20,21,22)
    Show/Hide
InChIKey
WIVGIKIKQHUFOD-UHFFFAOYSA-N
Physicochemical Property
logP
3.8361
Rotatable Bonds
5
Heavy Atom Count
26
Polar Areas
71.01
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16660135
SID: 26520171
ChEMBL ID
CHEMBL566581
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01994, Metabotropic glutamate receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 5.1 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 > 10000 nM
Protein ID: PT00854, Metabotropic glutamate receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( F-200 )
Drug Name F-200
Company Eos Biotechnology Inc
Indication
Ocular disease
Terminated